Austrian doctors push insurers to cover obesity drugs Ozempic, Mounjaro

Physicians in Austria are publicly demanding that health insurers cover GLP-1 weight-loss drugs for severe obesity, citing approval, efficacy, and tolerability, while noting that bariatric surgery is already reimbursed. The demand signals a potential shift in coverage policy, but no insurer or government response has been reported yet. If adopted, it could expand access to these high-cost drugs and affect public health budgets.